Prognostic factors of hemolytic uremic syndrome in renal allografts.
Candinas
D
D
Department of Surgery, University of Zurich Hospital, Switzerland.
Keusch
G
G
Schlumpf
R
R
Burger
H R
HR
Weder
W
W
Largiadèr
F
F
D000328:Adult; D002102:Cadaver; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D010951:Plasma Exchange; D011183:Postoperative Complications / Q000453:epidemiology / Q000628:therapy; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014810:Vitamin E / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D014810:Vitamin E